View : 922 Download: 212
Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis
- Title
- Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis
- Authors
- Hyun, Jae-Won; Park, Ji Hyun; Kang, Boo Gil; Park, Eun Young; Park, Boram; Joo, Jungnam; Kim, Jong Kuk; Kim, Su-Hyun; Jeong, Jee Hyang; Lee, Hyang Woon; Park, Kee Duk; Choi, Kyung Gyu; Hwang, Sang-Hyun; Gwak, Ho-Shin; Kim, Ho Jin
- Ewha Authors
- 박기덕; 이향운; 정지향
- SCOPUS Author ID
- 박기덕; 이향운; 정지향
- Issue Date
- 2017
- Journal Title
- ONCOTARGET
- ISSN
- 1949-2553
- Citation
- ONCOTARGET vol. 8, no. 32, pp. 53326 - 53335
- Keywords
- leptomeningeal carcinomatosis; diagnosis; prognosis; CSF; CYFRA 21-1
- Publisher
- IMPACT JOURNALS LLC
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Objectives: To investigate the diagnostic and prognostic values of cerebrospinal fluid (CSF) CYFRA 21-1 in patients with leptomeningeal carcinomatosis (LMC). Methods: Concentration of CSF CYFRA 21-1 was detected using electro-chemiluminescent immunoassay. The difference in level of CYFRA 21-1 between 61 patients with LMC and 200 patients with other neurological disease was evaluated, and diagnostic performance of CSF CYFRA 21-1 was investigated. In LMC patients treated with ventriculo-lumbar perfusion (VLP) chemotherapy, prognostic performance of CSF CYFRA 21-1 was evaluated. Results: The CSF CYFRA 21-1 was significantly higher in LMC patients than that in patients with other neurological diseases (p<0.001). The sensitivity, specificity, accuracy, and positive and negative predictive values were 80.3%, 95.0%, 91.6%, 83.1%, and 94.1% for CSF CYFRA 21-1, and 65.6%, 100%, 92.0%, 100%, and 90.5% for CSF cytology, respectively. The use of high CSF CYFRA 21-1 and/or positive CSF cytology findings resulted in an increased sensitivity of 85.3%, without compromising specificity. LMC patients with high CSF CYFRA 21-1 were more frequently accompanied by positive CSF cytology results than those with low CSF CYFRA 21-1. The median overall survival was longer in LMC patients with low CSF CYFRA 21-1 than in those with high CSF CYFRA 21-1 (p=0.031). During VLP chemotherapy, the clinical responses were found to be correlated with the biological responses, including the level of CSF CYFRA 21-1 and intracranial pressure. Conclusions: CSF CYFRA 21-1 might be regarded as an additional diagnostic tool for LMC and a potential significant prognostic biomarker in LMC patients treated with VLP chemotherapy.
- DOI
- 10.18632/oncotarget.18405
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
-
Diagnostic and prognostic values.pdf(2.35 MB)
Download
- Export
- RIS (EndNote)
- XLS (Excel)
- XML